Planning Solutions Group’s Novavax NVAX Stock Holding History

Planning Solutions Group’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-700	Closed	-$8K	–	142
2019 Q1	$8K	Sell	700 -135	-16%	-$4.26K	﹤0.01%	135
2018 Q4	$31K	Buy	+835	New	+$32.4K	0.02%	121

Other funds holding NVAX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Planning Solutions Group's NVAX Position: Q2 2019 in Review

Planning Solutions Group sold out of Novavax (NVAX) in Q2 2019, closing a stake of 700 shares — an estimated $8K sold.

Planning Solutions Group first reported a position in NVAX in Q4 2018 and held it in 2 quarters. The position peaked at $31K in Q4 2018. 81 funds tracked by Wall St. Rank hold NVAX as of Q2 2019.

Planning Solutions Group reported no remaining Novavax position as of Q2 2019 after selling out during the quarter.
Planning Solutions Group sold 700 Novavax shares in Q2 2019, an estimated $8K.
Planning Solutions Group first reported a position in Novavax in Q4 2018 and held it in 2 quarters.
Planning Solutions Group's Novavax position peaked at $31K in Q4 2018.
81 funds tracked by Wall St. Rank held Novavax as of Q2 2019.

Based on Planning Solutions Group's 13F filing for Q2 2019, filed 15 Aug 2019.